Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Aug 11:6:787.
doi: 10.3389/fmicb.2015.00787. eCollection 2015.

Temperature-sensitive mutations for live-attenuated Rift Valley fever vaccines: implications from other RNA viruses

Affiliations
Review

Temperature-sensitive mutations for live-attenuated Rift Valley fever vaccines: implications from other RNA viruses

Shoko Nishiyama et al. Front Microbiol. .

Abstract

Rift Valley fever (RVF) is a mosquito-borne zoonotic disease endemic to the African continent. RVF is characterized by high rate of abortions in ruminants and hemorrhagic fever, encephalitis, or blindness in humans. RVF is caused by the Rift Valley fever virus (RVFV: genus Phlebovirus, family Bunyaviridae). Vaccination is the only known effective strategy to prevent the disease, but there are no licensed RVF vaccines available for humans. A live-attenuated vaccine candidate derived from the wild-type pathogenic Egyptian ZH548 strain, MP-12, has been conditionally licensed for veterinary use in the U.S. MP-12 displays a temperature-sensitive (ts) phenotype and does not replicate at 41°C. The ts mutation limits viral replication at a specific body temperature and may lead to an attenuation of the virus. Here we will review well-characterized ts mutations for RNA viruses, and further discuss the potential in designing novel live-attenuated vaccines for RVF.

Keywords: MP-12; Rift Valley fever virus; bunyavirus; temperature sensitivity; vaccine.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Mapping of temperature-sensitive (ts) mutations for selected negative-stranded RNA viruses. The genome structures of RVFV MP-12 strain, Respiratory syncytial virus (RSV) cpts 248/404/1030, Influenza A virus (MDV-A), Influenza B virus (MDV-B), and Vesicular stomatitis virus (VSV) ts114 strain are shown. Viral genes are shown in different colors: Nucleocapsid protein (green), phosphoprotein (orange), RNA-dependent RNA polymerase (gray), envelope protein (yellow), matrix proteins (blue), and accessory or non-structural proteins (brown). Conserved six functional regions of RNA-dependent RNA polymerase (RdRp) among non-segmented negative-stranded RNA viruses are shown as I, II, III, IV, V, and VI, and those aligned to RdRp of bunyavirus and influenza virus are also indicated. Location of representative mutations and ts mutations (red square) are indicated by arrowheads. Putative ts mutations in the L-segment of MP-12 are shown in green squares. For RSV mutations, the name of clone, which encodes the mutation, is also shown in quotation.

Similar articles

Cited by

References

    1. Abu-Elyazeed R., El-Sharkawy S., Olson J., Botros B., Soliman A., Salib A., et al. (1996). Prevalence of anti-Rift-Valley-fever IgM antibody in abattoir workers in the Nile delta during the 1993 outbreak in Egypt. Bull. World Health Organ. 74 155–158. - PMC - PubMed
    1. Arita M., Shimizu H., Nagata N., Ami Y., Suzaki Y., Sata T., et al. (2005). Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys. J. Gen. Virol. 86 1391–1401. 10.1099/vir.0.807840 - DOI - PubMed
    1. Billecocq A., Spiegel M., Vialat P., Kohl A., Weber F., Bouloy M., et al. (2004). NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription. J. Virol. 78 9798–9806. 10.1128/JVI.78.18.9798-9806.2004 - DOI - PMC - PubMed
    1. Bird B. H., Ksiazek T. G., Nichol S. T., Maclachlan N. J. (2009). Rift Valley fever virus. J. Am. Vet. Med. Assoc. 234 883–893. 10.2460/javma.234.7.883 - DOI - PubMed
    1. Bird B. H., Maartens L. H., Campbell S., Erasmus B. J., Erickson B. R., Dodd K. A., et al. (2011). Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep. J. Virol. 85 12901–12909. 10.1128/JVI.06046-11 - DOI - PMC - PubMed

LinkOut - more resources